Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine Injection in Elderly AML
CTR20160527Phase 3Completed
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of decitabine in acute myeloid leukemia (AML), sponsored by Chia Tai-Tianqing Pharmaceutical Group. Started Aug 2016; status: completed.
02
Drugs
decitabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on CTR20160527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160527.